J Physiol Boston Smyposia
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 531, Number 1, 105-115, February 15, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhong, J.
Right arrow Articles by Keef, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhong, J.
Right arrow Articles by Keef, K. D.
Journal of Physiology (2001), 531.1, pp. 105-115
© Copyright 2001 The Physiological Society

beta-Adrenergic receptor stimulation of L-type Ca2+ channels in rabbit portal vein myocytes involves both alphas and betagamma G protein subunits


Juming Zhong, Joseph R. Hume and Kathleen D. Keef


Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA

MS 11079 Received 5 May 2000; accepted after revision 18 October 2000

  ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References

  1. Previous studies have shown that purified G protein alphas and betagamma subunits stimulate vascular L-type Ca2+ channels through protein kinase A and C (PKA and PKC), respectively. The present study tested whether activation of endogenous G proteins via beta-adrenergic receptor binding also stimulates vascular Ca2+ channels through both Galphas and Gbetagamma and the subsequent activation of PKA and PKC.

  2. Peak Ba2+ current (IBa) in freshly isolated rabbit portal vein smooth muscle cells was significantly increased by bath application of 0.5 muM isoproterenol (isoprenaline; ISO) when measured using the whole-cell patch clamp method (53 ± 3 % increase, n = 15). Stimulation of IBa by ISO was partially reversed by a PKA inhibitor, KT 5720, or a PKC inhibitor, calphostin C, and completely blocked when cells were pretreated with both KT 5720 and calphostin C.

  3. Dialysis of cells with polyclonal antibody to Galphas significantly reduced but did not completely eliminate ISO-induced stimulation of IBa. The remaining stimulation was abolished by calphostin C. Dialysis of cells with a polyclonal antibody to Gbeta also significantly reduced ISO-induced stimulation and the remaining stimulation was abolished by KT 5720. Dialysis of cells with both antibodies completely prevented the stimulation of IBa by ISO.

  4. ISO-induced stimulation of IBa was reversed by ICI-118,551, a specific beta2-adrenoceptor antagonist, but not by CGP 20712A, a specific beta1-adrenoceptor antagonist. In addition, the beta2-adrenoceptor agonist zinterol significantly increased peak IBa while the beta1-adrenoceptor agonist dobutamine and beta3-adrenoceptor agonist BRL 37344A had little effect on peak IBa.

  5. These data suggest that beta-adrenergic receptor stimulation of vascular L-type Ca2+ channels involves both alphas and betagamma G-protein subunits, which exert their effects through PKA and PKC, respectively.

  INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References

Ca2+ influx through L-type Ca2+ channels plays an important role in the regulation of contraction in vascular smooth muscle. In recent years a number of studies have suggested that beta-adrenergic receptor stimulation leads to enhancement of Ca2+ channel activity via G protein-dependent activation of cAMP-dependent protein kinase (PKA). Upon binding with agonist, the beta-adrenergic receptor promotes replacement of GDP with GTP on the G protein alphas subunit (Galphas). This in turn leads to dissociation of the GTP-bound Galphas subunit from the betagamma dimer (Gbetagamma). At present, the role of these G protein subunits in the excitatory effects of beta-adrenergic receptors on L-type Ca2+ channels in smooth muscle cells is still unclear.

Dissociated G protein subunits may interact with a number of different effectors such as adenylyl cyclases and ion channels (Hepler & Gilman, 1992; Clapham, 1994). Previous studies from our laboratory demonstrated that both purified Galphas and Gbetagamma subunits, when dialysed into cells, lead to the stimulation of L-type Ca2+ channel activity in rabbit portal vein myocytes (Zhong et al. 1999). Galphas was associated with activation of the adenylyl cyclase-PKA pathway whereas Gbetagamma was associated with activation of PKC. However, in the light of these observations the possible role of both endogenous Galphas and Gbetagamma in the beta-adrenergic receptor stimulation of L-type Ca2+ channels is still unknown. Whereas Galphas has long been considered to play a central role in the actions of beta-adrenergic receptor stimulation, the role of Gbetagamma is much less clear. Indeed, at present there is no information available concerning the potential role of Gbetagamma as a possible contributor to the actions of beta-adrenergic receptors on L-type Ca2+ channels.

In the present study, we investigated the role of endogenous Galphas and Gbetagamma in the modulation of L-type Ca2+ channels by beta-adrenergic receptor stimulation in rabbit portal vein smooth muscle myocytes. We used polyclonal antibodies directed against either the alphas or the beta G protein subunit. In addition, inhibitors of PKA and PKC were tested to determine whether one or both of these kinases contribute to the response, and specific beta-adrenoceptor agonists and antagonists were used to characterize the receptor subtype involved. Our results suggest that both Galphas and Gbetagamma participate in beta-adrenergic receptor stimulation of L-type Ca2+ channels, mediated by the PKA and PKC pathways, respectively.

  METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

Isolation of rabbit portal vein myocytes

Myocytes were isolated using previously described methods (Zhong et al. 1999). Male albino rabbits (1.5-2.0 kg) were killed with an intravenous overdose of sodium pentobarbital (50 mg kg-1). The portal vein was rapidly removed and cleaned of connective tissue in ice-cold Krebs solution (mM): 125 NaCl, 4.2 KCl, 1.2 MgCl2, 1.8 CaCl2, 11 glucose, 1.2 K2HPO4, 23.8 NaHCO3 and 11 Hepes, pH 7.4 with NaOH and bubbled with 95 % O2 and 5 % CO2. The portal vein was then cut into small segments (~4 mm X 4 mm) and pre-incubated for 30 min in a shaking water bath at 35 °C in a dispersion solution (enzyme-free, mM): 90 NaCl, 1.2 MgCl2, 1.2 K2HPO4, 20 glucose, 50 taurine and 5 Hepes, pH 7.1 with NaOH. Following pre-incubation, the segments were incubated in the dispersion solution containing 2 mg ml-1 collagenase type I (Sigma), 0.5 mg ml-1 protease type XXVII (Sigma) and 2 mg ml-1 bovine serum albumin (Sigma) for 10-14 min at 35 °C, and then rinsed 4 times with enzyme-free dispersion solution. Smooth muscle cells were dispersed by gentle trituration of the segments with a wide-tipped fire-polished Pasteur pipette. The cell suspension was stored in enzyme-free dispersion solution containing BSA (1 mg ml-1) and Ca2+ (0.1 mM) at 4 °C and used within 10 h. The animal use protocol was reviewed and approved by the Animal Care and Use Committee of the University of Nevada.

Electrophysiology

Ba2+ currents (IBa) in portal vein smooth muscle cells were measured using the whole-cell patch clamp technique. A drop of cell suspension was added to a small recording chamber mounted on the stage of an inverted microscope (Nikon, Japan). The cells were allowed to settle down to the bottom of the chamber and superfused at a constant rate (~1-2 ml min-1). Inward currents were measured using an Axopatch-1D patch clamp amplifier (Axon Instruments). Patch electrodes were made from borosilicate glass pulled with a Sutter P-87 Flaming/Brown micropipette horizontal puller and fire polished with a MF-83 Narishige microforge (Japan). Pipette resistance was 3-5 MOmega when filled with the pipette solution. After establishing the whole-cell configuration, cell membrane capacitance and series resistance were determined using a 20 mV hyperpolarizing pulse and were partially compensated. Inward current was elicited by stepping the voltage to 0 mV from a holding potential of -70 mV at 30 s intervals. Voltage clamp protocols were applied to the cells using the data acquisition package pCLAMP 7 (Axon Instruments) and filtered at 2 kHz. Data analysis was performed using the pCLAMP 7 software package. All the experiments were performed at room temperature (20-23 °C).

The bath solution used to record IBa in portal vein cells was composed of (mM): 117.5 NaCl, 10 TEACl, 5 BaCl2, 0.5 MgCl2, 5.5 glucose, 5 CsCl and 10 Hepes, pH 7.40 with NaOH. Both TEACl and CsCl were used to block K+ currents. The pipette solution contained (mM): 120 CsCl, 20 TEACl, 1 K2HPO4, 5.5 glucose, 5.7 MgCl2, 5 ATP, 0.5 GTP, 10 EGTA and 10 Hepes, pH 7.2 with CsOH.

Drugs

Isoproterenol (ISO) and chemicals were purchased from Sigma. Dobutamine, ICI 118,551 and CGP 20712A were from RBI (Natick, MA, USA). KT 5720 and calphostin C were from CalBiochem (La Jolla, CA, USA). Rp-8-Br-PET-cGMPS was from Biolog (La Jolla, CA, USA). Zinterol was a generous gift from Dr Iain Buxton, Department of Pharmacology, University of Nevada School of Medicine. Antibodies to G protein subunits were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The anti-Galphas antibody is a rabbit polyclonal IgG raised against an epitope mapping within the N-terminal domain of human Galphas. The anti-Gbetacom antibody is a rabbit polyclonal antibody raised against a peptide mapping to the C-terminal domain of mouse Gbeta and is reactive with all four subtypes of Gbeta. Drugs insoluble in water were first dissolved in dimethylsulphoxide (DMSO) and were then further diluted in the solution with the final concentration of DMSO less than 0.2 %. DMSO alone at a concentration of 0.2 % had no effect on IBa.

Data analysis

All experimental values are presented as means ± S.E.M., and n refers to the number of cells tested. Differences between the values from different groups were compared using Student's paired and unpaired t tests, and two-way analysis of variance, where appropriate. P values of less than 0.05 were considered significantly different.

  RESULTS
Top
Abstract
Introduction
Methods
Results
Discussion
References

ISO-induced stimulation of IBa is completely abolished by inhibitors of both PKA and PKC

Ba2+ currents through L-type Ca2+ channels were recorded in freshly isolated rabbit portal vein myocytes using the whole-cell voltage clamp technique. The beta-adrenergic receptor agonist isoproterenol (ISO) was used to stimulate beta-adrenoceptors. Previous studies from our laboratory have shown that the inward current recorded from these cells under similar experimental conditions was blocked by nicardipine. In addition, low concentrations of ISO (< 1 muM) produced constant stimulation of Ca2+ channel currents in rabbit portal vein cells while higher concentrations of ISO were associated with a transient increase followed by a reduction in current due to 'cross-activation' of protein kinase G (PKG; Ishikawa et al. 1993). Thus low concentrations (0.5-1 muM) of ISO were used in this study. Once steady-state current amplitudes were obtained in the whole-cell configuration, ISO (0.5 muM) was added to the superfusate, which caused a significant increase in peak IBa (mean peak IBa with ISO was 155 ± 5 % of basal current, n = 10; Fig. 1). Application of KT 5720 (0.2 muM), a specific PKA inhibitor, significantly reduced, but did not abolish, the ISO-induced stimulation of peak IBa. The peak IBa that remained in the presence of KT 5720 was 21 ± 4 % higher than the peak IBa recorded under basal conditions (Fig. 1). The current stimulation that remains is unlikely to be due to incomplete blockade of PKA since we have previously shown that this concentration of KT 5720 completely blocks the stimulation that occurs when cells are dialysed with the catalytic subunit of PKA or activated G protein alphas subunits (Ruiz-Velasco et al. 1998; Zhong et al. 1999). These results suggest that PKA significantly contributes to beta-adrenergic receptor stimulation of Ca2+ channels in these cells but that another pathway(s) independent of PKA is also likely to be involved.

View larger version
[in this window]
[in a new window]

    Figure 1 ISO-enhanced Ca2+ channel current in rabbit portal vein myocytes is not entirely reversed by PKA inhibitor

    Currents were elicited by stepping the membrane potential to 0 mV from a holding potential of -70 mV. A, superimposed recordings from a cell in the absence (1) or presence (2) of ISO (0.5 muM) or presence (3) of ISO and KT 5720 (PKA inhibitor, 0.2 muM). B, time course of peak IBa from a cell before and after addition of ISO and KT 5720. ISO and KT 5720 were added to the superfusate when peak current reached a steady state. C, percentage change of peak IBa in the presence of ISO or ISO plus KT 5720 compared with the values in the absence of any drugs. Values represent means ± S.E.M. and asterisks indicate a significant difference from values before ISO application (P < 0.05).

To further investigate the nature of the PKA-independent response to ISO, cells were superfused with KT 5720 (0.2 muM), calphostin C (a PKC inhibitor, 0.2 muM), or KT 5720 plus calphostin C (0.2 muM each), before and during application of ISO. When ISO (0.5 muM) was added in the presence of KT 5720 it still resulted in a 17 ± 1 % increase in peak IBa (n = 13, Fig. 2C). This is very similar to the magnitude of current stimulation that remained when KT 5720 was added after ISO (Fig. 1C). Similarly, when ISO was added in the presence of calphostin C peak IBa increased by 31 ± 3 % (Fig. 2C), which is very similar to the magnitude of current stimulation that remained when calphostin C was added after ISO (i.e. 30 ± 4 %, n = 3, data not shown). On the other hand, the combined application of KT 5720 plus calphostin C produced complete blockade of ISO-induced stimulation of IBa (n = 11, Fig. 2). These data suggest that the PKA-independent response to ISO is likely to be due to PKC.

Since high levels of cAMP can lead to cross-activation of PKG (Lincoln et al. 1990), some experiments with ISO were repeated when cells were first superfused with the PKG inhibitor Rp-8-Br-cGMPS (Rp-PET). The increase in peak current produced with ISO (1 muM) plus Rp-PET was not significantly greater than the response measured in the absence of Rp-PET (i.e. 67 ± 7 vs. 55 ± 5 %). To further investigate the possible role of PKG in the ISO response, calphostin C and KT 5720 were added to cells pretreated with Rp-PET and stimulated with ISO. Combined calphostin C plus KT 5720 entirely abolished ISO-induced stimulation of IBa in the presence of Rp-PET (n = 7, data not shown) as it did in the absence of Rp-PET (Fig. 2C), suggesting that PKG effects do not significantly contaminate the results obtained with 1 muM ISO.

View larger version
[in this window]
[in a new window]

    Figure 2 ISO-enhanced Ca2+ channel current in rabbit portal vein myocytes is entirely abolished by combined PKA and PKC inhibitors

    A, time course of peak current recordings from a cell before and after application of ISO (0.5 muM) in the presence of KT 5720 (0.2 muM). B, time course of peak current recordings from a cell before and after application of ISO in the presence of KT 5720 and calphostin C (0.2 muM). C, percentage change of peak IBa after application of ISO in the presence of KT 5720, calphostin C, or KT 5720 plus calphostin C. Numbers in parentheses indicate the number of cells tested. Values represent means ± S.E.M. and asterisks indicate a significant difference from values before ISO application (P < 0.05).

ISO-induced stimulation of IBa is completely attenuated by antibodies to Galphas and Gbeta

A previous study from our laboratory showed that either purified alphas or betagamma G protein subunits stimulate Ca2+ channel currents in rabbit portal vein myocytes (Zhong et al. 1999). However, it is unclear whether both of these G protein subunits are involved in the response to beta-adrenergic receptor stimulation. To examine the role of Gbetagamma in the actions of ISO, cells were first dialysed with anti-Galphas antibody (10 mug ml-1) and Ba2+ currents were measured before and after addition of ISO. In the presence of anti-Galphas antibody, ISO still gave rise to an increase in peak IBa, but this increase was significantly smaller than the stimulatory effect of ISO in control cells without antibody (18 ± 3 vs. 55 ± 5 % increase, respectively; see Figs 1 and 3). The stimulation of peak IBa by ISO in the presence of anti-Galphas antibody was reversed by calphostin C, but not by KT 5720 (Fig. 3). When the amount of anti-Galphas antibody in the patch pipette was doubled (20 mug ml-1) there was no further reduction in the stimulatory effect of ISO on IBa (i.e. 19 ± 2 % increase, n = 5, data not shown) suggesting that 10 mug ml-1 fully blocks Galphas. To isolate the Galphas component of the response to ISO, cells were first dialysed with anti-Gbeta antibody (10 mug ml-1) and Ba2+ currents were measured before and after addition of ISO. In the presence of anti-Gbeta antibody, ISO still elicited a 19 ± 3 % increase in peak IBa. This increase of peak IBa was entirely reversed by KT 5720, but not by calphostin C (Fig. 4). When the amount of anti-Gbeta antibody in the patch pipette was doubled (20 mug ml-1) there was no further reduction in the stimulatory effect of ISO (16 ± 1 % increase, n = 3, data not shown) suggesting that the Gbeta subunit was fully blocked with 10 mug ml-1 of antibody. These data suggest that neither antibody, when used alone, completely prevents the stimulatory effect of ISO on Ca2+ channel activity. In contrast, 10 mug ml-1 of the same anti-Gbeta antibody was sufficient to abolish the angiotensin II-induced stimulation of Ca2+ channels in rat portal vein myocytes (Macrez et al. 1997).

View larger version
[in this window]
[in a new window]

    Figure 3 The Galphas-independent effect of ISO is abolished by PKC inhibitor

    Cells were dialysed with anti-Galphas antibody (10 mug ml-1) and currents recorded every 30 s. ISO (1 muM) was added to the bath solution when current reached a steady state. A, time course of peak current recordings from a cell dialysed with anti-Galphas antibody in the absence and presence of ISO and calphostin C (0.2 muM). B, percentage change of peak IBa after application of ISO and kinase inhibitors. Numbers in parentheses indicate the number of cells tested. Values represent means ± S.E.M. and asterisks indicate a significant difference from values before ISO application (P < 0.05).

View larger version
[in this window]
[in a new window]

    Figure 4 The Gbetagamma-independent effect of ISO is abolished by PKA inhibitor

    Cells were dialysed with anti-Gbeta antibody (10 mug ml-1) and currents recorded every 30 s. ISO (1 muM) was added into the bath solution when current reached a steady state. A, time course of peak current recordings from a cell dialysed with anti-Gbeta antibody in the absence and presence of ISO and KT 5720 (0.2 muM). B, percentage change of peak IBa after application of ISO and kinase inhibitors. Numbers in parentheses indicate the number of cells tested. Values represent means ± S.E.M. and asterisks indicate a significant difference from values before ISO application (P < 0.05).

Our results suggest that the ISO-induced response consists of two components, one initiated by Galphas, which leads to the stimulation of PKA, and one initiated by Gbetagamma, which leads to the stimulation of PKC. To further explore this hypothesis, additional experiments were undertaken in which cells were dialysed with combined anti-Galphas antibody and anti-Gbetagamma antibody (10 mug ml-1 each). Peak IBa measured following addition of ISO was not different from that recorded before addition of ISO when cells were dialysed with both anti-Galphas and anti-Gbeta antibodies (Fig. 5). This complete block was not due to the greater amount of antibody used since neither 20 mug ml-1 of anti-Galphas antibody alone nor 20 mug ml-1 of anti-Gbeta antibody alone produced complete block of ISO-induced stimulation (see above).

View larger version
[in this window]
[in a new window]

    Figure 5 Combined antibodies to Galphas and Gbeta subunits prevent ISO-induced stimulation of peak IBa in rabbit portal vein myocytes

    A, time course of peak current recordings from a cell dialysed with anti-Galphas and anti-Gbeta (10 mug ml-1 each) in the absence and presence of ISO. Cells were dialysed with anti-Galphas and anti-Gbeta antibodies and currents recorded every 30 s. ISO (1 muM) was added to the bath solution when current reached a steady state. B, peak IBa in cells dialysed with anti-Galphas plus anti-Gbeta (10 mug ml-1) before and after application of ISO (n = 11). Values represent means ± S.E.M. There was no significant difference between the values before and after application of ISO.

beta2-Adrenoceptor agonist is a potent stimulator of IBa in rabbit portal vein myocytes

Results from the above experiments as well as other reports indicate that beta-adrenergic receptor activation leads to the stimulation of L-type Ca2+ channels in vascular smooth muscle cells. Although it is well established that beta2-adrenoceptors mediate relaxation of vascular smooth muscle, it is not clear which subtype of beta-adrenergic receptor is responsible for the beta-adrenoceptor-induced stimulation of Ca2+ channels. This question was examined for rabbit portal vein cells in two ways. First, we tested subtype-specific beta-adrenoceptor antagonists. A previous study from our laboratory showed that the ISO-induced stimulation of IBa was completely abolished by propranolol, a non-selective beta1- and beta2-adrenoceptor antagonist (Ishikawa et al. 1993). In the present study we tested the effects of the more specific beta1- and beta2-adrenoceptor antagonists CGP 20712A and ICI 118,551, respectively (Bilski et al. 1983; Laflamme & Becker, 1998; Schroder & Herzig, 1999). Figure 6 shows the effects of either ICI 181,551 or CGP 20712A on ISO-induced stimulation of Ca2+ channel current. In the presence of 5 muM ICI 181,551, stimulation of peak IBa by ISO was entirely abolished (Fig. 6A). On the other hand, 5 muM CGP 20712A failed to block the ISO-induced stimulation (Fig. 6B). The average increase of peak IBa by ISO in the presence of CGP 20712A was not significantly different from control, while there was no increase of peak IBa by ISO in the presence of ICI 181,551 (Fig. 6C).

View larger version
[in this window]
[in a new window]

    Figure 6 ISO-induced stimulation of IBa is abolished by beta2-adrenoceptor antagonist

    Cells were superfused with ICI 181,551 (beta2-adrenoceptor antagonist) or CGP 20712A (beta1-adrenoceptor antagonist) before application of ISO (1 muM). ISO was added into the bath solution when peak current reached a steady state. A, time course of peak current recordings from a cell superfused with ICI 181,551 (5 muM) before and after addition of ISO. B, time course of peak current recordings from a cell superfused with CGP 20712A (5 muM) before and after addition of ISO. C, percentage change of peak current after application of ISO in the absence or presence of ICI 181,551 or CGP 20712A. Numbers in parentheses indicate the number of cells tested. Values represent means ± S.E.M. and asterisks indicate a significant difference from values before application of ISO (P < 0.05).

The role of beta-adrenoceptor subtypes was also examined by testing the effects of more specific beta-adrenoceptor subtype agonists on Ca2+ channel currents. Surprisingly, zinterol, a potent beta2-adrenoceptor agonist (Laflamme & Becker, 1998; Schroder & Herzig, 1999), at concentrations from 1 up to 10 muM did not stimulate Ba2+ current in most cells and even reduced peak IBa in some cells tested, and dobutamine, a potent beta1-adrenoceptor agonist (Doggrell, 1990), at 10 muM concentration did not have any detectable effect on Ca2+ channels (data not shown). We then repeated the experiments in the presence of Rp-8-Br-PET-cGMPS (Rp-PET, 1 muM), a specific PKG inhibitor, to determine whether the effects of the beta-adrenoceptor agonists might be masked by the well-established ability of high cAMP concentrations to cross-activate PKG (Lincoln et al. 1990; Ruiz-Velasco et al. 1998). Application of Rp-PET itself increased peak IBa by about 10 %. In the presence of Rp-PET, zinterol (1 muM) led to a large increase in peak IBa of approximately 80 %. On the other hand, neither the beta1-adrenoceptor agonist dobutamine (1 muM) nor the beta3-adrenoceptor agonist BRL 37344A (1 muM) (Oriowo et al. 1996) had a detectable effect on IBa in the presence of Rp-PET (Fig. 7). These experiments suggest that beta2-adrenoceptors are the predominant receptor subtype underlying beta-adrenoceptor-induced stimulation of L-type Ca2+ channels in rabbit portal vein myocytes.

View larger version
[in this window]
[in a new window]

    Figure 7 The beta2-adrenoceptor agonist zinterol is a potent stimulator of Ca2+ channels in rabbit portal vein myocytes

    Cells were first superfused with normal bath solution and current recorded. When peak current reached a steady state, cells were then superfused with bath solution containing Rp-8-Br-PET-cGMPS (Rp-PET; PKG inhibitor, 1 muM), followed by addition of Rp-PET plus dobutamine (dob, 1 muM), BRL 37344A (BRL, 1 muM) or zinterol (zin, 1 muM). The inset shows superimposed representative recordings from a cell before (1) and after application of Rp-PET (2), and after application of zinterol in the presence of Rp-PET (3). The bar graph shows the averaged percentage increase of peak current after application of different drugs in the presence of Rp-PET. Numbers in parentheses indicate the number of cells tested. Values represent means ± S.E.M. and asterisks indicate a significant difference from the value with Rp-PET alone (control, P < 0.05).

  DISCUSSION
Top
Abstract
Introduction
Methods
Results
Discussion
References

The beta-adrenergic receptor is coupled to the G protein Gs, which is composed of a Galphas and a Gbetagamma subunit. Galphas has long been known to play a central role in responses evoked with beta-adrenergic receptor stimulation because of its ability to activate adenylyl cyclase, leading to the stimulation of PKA and phosphorylation of various proteins. On the other hand, there is increasing evidence to suggest that Gbetagamma also plays an important regulatory role in modulating a variety of downstream effectors (Hepler & Gilman, 1992; Clapham, 1994). Our results suggest that stimulation of vascular Ca2+ channels via activation of beta-adrenergic receptors involves both the Galphas and the Gbetagamma subunit and that different downstream mediators are involved, namely PKA and PKC, respectively.

In cardiac muscle, beta-adrenergic receptor stimulation has long been known to lead to the activation of L-type Ca2+ channels and the primary mediator of this effect has generally been assumed to be the Galphas-adenylyl cyclase-PKA pathway (McDonald et al. 1994; Xiong & Sperelakis, 1995). In addition, PKA phosphorylation sites on both the alpha and beta subunits of the cardiac L-type Ca2+ channel have also been identified (Gao et al. 1997; Gerhardstein et al. 1999). The vascular L-type Ca2+ channel alpha1C subunit shares 93 % homology with the cardiac Ca2+ channel alpha1C subunit and contains the same phosphorylation site on the carboxy terminus (Stea et al. 1995). In addition, vascular L-type Ca2+ channels have been shown to be stimulated by exogenous Galphas, by 8-Br-cAMP and forskolin and by application of the catalytic subunit of PKA (Fukumitsu et al. 1990; Loirand et al. 1992; Ishikawa et al. 1993; Tewari & Simard, 1994; Shi & Cox, 1995; Farrugia, 1997; Liu et al. 1997; Ruiz-Velasco et al. 1998). The present study provides additional evidence suggesting an important role for the Galphas-PKA pathway in the regulation of L-type Ca2+ channels by beta-adrenergic receptors. The ISO-induced stimulation of Ca2+ channels was reduced to less than half by dialysis of cells with anti-Galphas antibody or by superfusion of cells with the PKA inhibitor KT 5720. Furthermore, when the Gbetagamma pathway was eliminated by dialysis of cells with anti-Gbeta antibody, the remaining ISO-induced stimulation of Ca2+ channel current was entirely abolished by KT 5720.

Modulation of L-type Ca2+ channels by G protein betagamma subunits has received much less attention although betagamma subunits of G proteins have been shown to modulate many effectors in different pathways (Clapham & Neer, 1993, 1997; De et al. 1997; Dolphin, 1998). Using an anti-G protein beta subunit antibody, Macrez et al. (1997) provided evidence that the betagamma dimer of G13 was responsible for the angiotensin II-induced stimulation of L-type Ca2+ channels in rat portal vein myocytes. In addition, direct dialysis of cells with purified Gbetagamma subunits has been shown to increase Ca2+ channel currents in both rabbit and rat portal vein myocytes (Zhong et al. 1999; Viard et al. 1999). The present study provides evidence that the Gbetagamma pathway also contributes to beta-adrenergic receptor stimulation in rabbit portal vein. ISO-induced stimulation of Ca2+ channel current was reduced when cells were dialysed with anti-Gbeta antibody and complete blockade only occurred when anti-Galphas antibody was combined with anti-Gbeta antibody. Thus in rabbit portal vein myocytes the Gbetagamma subunit, in addition to Galphas, appears to be involved in the actions of ISO.

The Galphas antibody used in the present study was a rabbit polyclonal IgG raised against an epitope mapping within the N-terminal domain of human Galphas. The N-terminus of Galpha subunits interacts strongly with Gbetagamma in the GDP-binding state and is located near the plasma membrane surface (Conklin & Bourne, 1993). Thus, anti-Galphas antibody may not have access to the binding region when Galphas is associated with Gbetagamma. Blockade with anti-Galphas antibody is therefore predicted to occur following dissociation of Galphas from Gbetagamma. Under these conditions a specific block of Galphas can be achieved as opposed to the general G protein block attained when antibody directed towards the C-terminus of the Galpha subunit is used. The C-terminal region of the Galpha subunit is the site at which receptor activation occurs. Without receptor activation the Galpha subunit no longer dissociates from Gbetagamma and both Galpha and Gbetagamma effects are removed (Macrez et al. 1997).

In a previous study we concluded that the action of exogenous Gbetagamma on L-type Ca2+ channels was due to activation of PKC since the enhancement of current by Gbetagamma was blocked by calphostin C, a specific PKC inhibitor, but not by PKA inhibitors (Zhong et al. 1999). No evidence for a direct membrane-delimited action of Gbetagamma on the Ca2+ channel was obtained. This conclusion is in agreement with studies by others reporting that Gbetagamma subunits have no direct effect on alpha1C L-type Ca2+ channel subunits (Dolphin, 1998). Furthermore, Gbetagamma does not appear to have a direct effect on either type V or type VI adenylyl cyclases (cardiac and smooth muscle types) (Tang & Gilman, 1992; Ishikawa & Homcy, 1997). In the present study, complete blockade of ISO-induced stimulation of Ca2+ channels required a combination of PKA and PKC inhibitors, suggesting that PKC contributes to the actions of ISO on Ca2+ channels. In addition, the ISO-induced stimulation of Ca2+ channel currents obtained in the presence of anti-Galphas antibody was completely reversed by calphostin C, suggesting that PKC is activated by the Gbetagamma subunit. There are a number of different possible pathways by which Gbetagamma may lead to stimulation of PKC, such as Gbetagamma-activated phospholipase C, D and A2 (Cockcroft, 1992; Clapham & Neer, 1997). In cultured vascular smooth muscle cells it was suggested that angiotensin II stimulates phospholipase D (PLD) via Gbetagamma since PLD activation was inhibited when cells were electroporated with anti-Gbeta antibody as well as in cells over-expressing the Gbetagamma-binding region of betaark-1 (Ushio-Fukai et al. 1999). In a recent study of L-type Ca2+ channels in rat portal vein cells (Viard et al. 1999) it was suggested that Gbetagamma may activate PKC via phosphoinositide 3-kinase (PI3K) since infusion of cells with purified PI3Kgamma mimicked Gbetagamma-induced stimulation of Ca2+ channels, and since both Gbetagamma- and PI3Kgamma-induced stimulation of Ca2+ channel currents were reduced by PKC inhibitors. Although it is not clear what specific betagamma combination of G protein is coupled with alphas in the present study, it appears that many different combinations of beta and gamma subunits (except beta1gamma1) have similar actions (Ueda et al. 1994; Dolphin, 1998). In fact, recent studies from our laboratory (Zhong et al. 1999) and the Mironneau laboratory (Viard et al. 1999) demonstrated that both the recombinant G protein beta1gamma2 from SF9 cells and a purified betagamma subunit from bovine brain Gi/Go protein could stimulate L-type Ca2+ channels via PKC activation in rabbit and rat portal vein smooth muscle cells.

It has generally been accepted that the predominant subtype of beta-adrenergic receptor present in vascular smooth muscle cells is the beta2-adrenoceptor (Bevan et al. 1980). For example, in the rat portal vein, spontaneous contractile activity was inhibited by ISO but not by the beta1-adrenoceptor agonist dobutamine, and the response to ISO was antagonized by propranolol, metoprolel and ICI 118,551, suggesting that the rat portal vein contains predominantly beta2-adrenoceptors (Doggrell, 1990). On the other hand, there is evidence that vascular beta-adrenoceptors may not be homogeneous in different vascular beds as well as in different species. For instance, although beta1-adrenoceptors predominate in canine facial vein, in canine saphenous vein beta2-adrenoceptors predominate (Tsuru & Negita, 1989). In rat carotid artery there may be a mixed population of all three subtypes of beta-adrenoceptor (MacDonald et al. 1999). A recent study from Viard et al. (2000) suggests that beta3-adrenoceptor activation can also stimulate L-type Ca2+ channels in rat portal vein myocytes. In contrast, a previous study from our laboratory suggested that the ISO-induced stimulation of L-type Ca2+ channels in rabbit portal vein myocytes was due to either beta1- or beta2-adrenoceptors since the response was abolished by propranolol (Ishikawa et al. 1993). The results from the present study suggest that the stimulatory effect of ISO on rabbit portal vein L-type Ca2+ channels is due to beta2-adrenoceptors since the response was inhibited by the beta2-adrenoceptor antagonist ICI 118,551, but not by the beta1-adrenoceptor antagonist CGP 20712A. In addition, the beta2-adrenoceptor agonist zinterol, but not the beta2- or beta3-adrenoceptor agonists dobutamine and BRL 37344A, significantly increased peak IBa in cells. The requirement for a PKG inhibitor to reveal the stimulatory effect of zinterol on Ca2+ channels in these cells is probably due to the known cross-talk that can occur between cAMP and PKG when cAMP levels are high (Lincoln et al. 1990). In previous studies we have shown that the cGMP-PKG pathway inhibits L-type Ca2+ channels in rabbit portal vein cells and that higher levels of cAMP predominantly inhibit L-type Ca2+ channels via activation of PKG (Ishikawa et al. 1993; Ruiz-Velasco et al. 1998). The concentration of zinterol that we used (1 muM) has been shown to generate more cAMP than either ISO or noradrenaline (norepinephrine) in GH3 cells expressing beta1- and beta2-adrenoceptors (Guerrero & Minneman, 1999). Cross-activation of PKG during ISO application was avoided in the present study by using a concentration of ISO that produced only enhancement of Ca2+ channel currents. This was confirmed by the fact that the ISO-induced increase in current magnitude was not significantly different in the presence or absence of the PKG blocker Rp-PET. Our experiments with Rp-PET also suggest that PKG does not 'mask' an additional stimulatory component since the ISO response was still entirely abolished by combined PKA and PKC blockade in the presence of Rp-PET.

Although there is a diversity of functional beta-adrenoceptor subtypes, these different subtypes (especially beta1 and beta2) may mobilize similar signal transduction pathways. Specifically, available evidence suggests that both beta1- and beta2-adrenoceptor stimulation of cardiac L-type Ca2+ channels involves activation of the adenylyl cyclase- cAMP-PKA pathway. On the other hand, beta2-adrenoceptors may also exert an effect through other signalling pathways, such as coupling to Gi protein as well as some G protein-independent signalling pathway (Steinberg, 1999). In the present study, the stimulatory effect of ISO on L-type Ca2+ channels was antagonized by dialysing cells with antibodies to G protein alphas and betagamma subunits, suggesting a requirement for the Gs protein in the signalling pathway. The results expand upon earlier studies in suggesting that PKC as well as PKA contribute to the actions of Gs on IBa.

In conclusion, our results suggest that beta-adrenergic receptor stimulation of vascular L-type Ca2+ channels involves both alphas and betagamma G protein subunits and that these subunits exert their effects through the PKA and PKC pathways, respectively. This conclusion is in agreement with our previous studies in which activated G protein subunits were applied exogenously to cells via dialysis (Zhong et al. 1999). These data, along with results obtained for angiotensin II receptor stimulation by others (Macrez et al. 1997), suggest that the Gbetagamma subunit and PKC may make an important contribution to the regulation of vascular L-type calcium channels following stimulation of a diverse range of G protein-coupled receptors. It is possible that this novel signalling pathway involving Gbetagamma and PKC may in fact be responsible for the PKA-independent regulation of vascular L-type Ca2+ channels by ISO described in earlier studies (Xiong & Sperelakis, 1995) and attributed to a membrane-delimited action of G protein alphas subunits.

  REFERENCES
Top
Abstract
Introduction
Methods
Results
Discussion
References

BEVAN J. A., BEVAN, R. D. & DUCKLES, S. P. (1980). Adrenergic regulation of vascular smooth muscle. In Handbook of Physiology, section 2, The Cardiovascular System, ed. BOHR, D. F., SOMLYO, A. P. & SPARKS, H. V. JR, pp. 515-566. American Physiological Society, Bethesda, MD, USA
BILSKI A. J., HALLIDAY, S. E., FITZGERALD, J. D. & WALE, J. L. (1983). The pharmacology of a beta2-selective adrenoceptor antagonist (ICI 118,551). Journal of Cardiovascular Pharmacology 5, 430-437 [Medline]
BUNEMANN M. & HOSEY, M. M. (1999). G-protein coupled receptor kinases as modulators of G-protein signalling. Journal of Physiology 517, 5-23 [Full Text]
CLAPHAM D. E. (1994). Direct G protein activation of ion channels? Annual Review of Neurosciences 17, 441-464.

,

CLAPHAM D. E. & NEER, E. J. (1993). New roles for G-protein betagamma-dimers in transmembrane signaling. Nature 365, 403-406 [Medline]
CLAPHAM D. E. & NEER, E. J. (1997). G protein betagamma subunits. Annual Review of Pharmacology and Toxicology 37, 167-203 [Abstract/Full Text]
COCKCROFT S. (1992). G-protein-regulated phospholipases C, D and A2-mediated signaling in neutrophils. Biochimica et Biophysica Acta 1113, 135-160 [Medline]
CONKLIN B. R. & BOURNE, H. R. (1993). Structural elements of G alpha subunits that interact with G betagamma, receptors, and effectors. Cell 73, 631-641 [Medline]
DE W. M., LIU, H., WALKER, D., SCOTT, V. E., GURNETT, C. A. & CAMPBELL, K. P. (1997). Direct binding of G-protein betagamma complex to voltage-dependent calcium channels. Nature 385, 446-450 [Medline]
DOGGRELL S. A. (1990). Assessment of the beta2 adrenoceptor and Ca2+ channel-blocking activity of drugs with the rat portal vein. Journal of Pharmacological Methods 24, 145-156 [Medline]
DOLPHIN A. C. (1998). Mechanisms of modulation of voltage-dependent calcium channels by G proteins Journal of Physiology 506, 3-11. [Abstract/Full Text]
FARRUGIA G. (1997). G-protein regulation of an L-type calcium channel current in canine jejunal circular smooth muscle. Journal of Membrane Biology 160, 39-46 [Medline]
FUKUMITSU T., HAYASHI, H., TOKUNO, H. & TOMITA, T. (1990). Increase in calcium channel current by beta-adrenoceptor agonists in single smooth muscle cells isolated from porcine coronary artery. British Journal of Pharmacology 100, 593-599 [Medline]
GAO T., YATANI, A., DELL'ACQUA, M. L., SAKO, H., GREEN, S. A., DASCAL, N., SCOTT, J. D. & HOSEY, M. M. (1997). cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 19, 185-196 [Medline]
GERHARDSTEIN B. L., PURI, T. S., CHIEN, A. J. & HOSEY, M. M. (1999). Identification of the sites phosphorylated by cyclic AMP-dependent protein kinase on the beta2 subunit of L-type voltage-dependent calcium channels. Biochemistry 38, 10361-10370
GUERRERO S. W. & MINNEMAN, K. P. (1999). Coupling efficiencies of beta1- and beta2-adrenergic receptors expressed alone or together in transfected GH3 pituitary cells. Journal of Pharmacology and Experimental Therapeutics 290, 980-988 [Abstract/Full Text]
HEPLER J. R. & GILMAN, A. G. (1992). G proteins. Trends in Biochemical Sciences 17, 383-387 [Medline]
ISHIKAWA T., HUME, J. R. & KEEF, K. D. (1993). Regulation of Ca2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circulation Research 73, 1128-1137 [Abstract]
ISHIKAWA Y. & HOMCY, C. (1997). The adenylyl cyclases as integrators of transmembrane signal transduction. Circulation Research 80, 297-304 [Full Text]
LAFLAMME M. A. & BECKER, P. L. (1998). Do beta2-adrenergic receptors modulate Ca2+ in adult rat ventricular myocytes? American Journal of Physiology 274, H1308-1314. [Medline]
LINCOLN T. M., CORNWELL, T. L. & TAYLOR, A. E. (1990). cGMP-dependent protein kinase mediates the reduction of Ca2+ by cAMP in vascular smooth muscle cells. American Journal of Physiology 258, C399-407 [Medline]
LIU H., XIONG, Z. & SPERELAKIS, N. (1997). Cyclic nucleotides regulate the activity of L-type calcium channels in smooth muscle cells from rat portal vein. Journal of Molecular and Cellular Cardiology 29, 1411-1421 [Medline]
LOIRAND G., FAIDERBE, S., BARON, A., GEFFARD, M. & MIRONNEAU, J. (1992). Autoanti-phosphatidylinositide antibodies specifically inhibit noradrenaline effects on Ca2+ and Cl- channels in rat portal vein myocytes. Journal of Biological Chemistry 267, 4312-4316 [Abstract]
LU T., LEE, H. C., KABAT, J. A. & SHIBATA, E. F. (1999). Modulation of rat cardiac sodium channel by the stimulatory G protein alpha subunit. Journal of Physiology 518, 371-384 [Abstract/Full Text]
MACDONALD A., MCLEAN, M., MACAULAY, L. & SHAW, A. M. (1999). Effects of propranolol and L-NAME on beta-adrenoceptor-mediated relaxation in rat carotid artery. Journal of Autonomic Pharmacology 19, 145-149 [Medline]
MCDONALD T. F., PELZER, S., TRAUTWEIN, W. & PELZER, D. J. (1994). Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiological Reviews 74, 365-507 [Medline]
MACREZ N., MOREL, J. L., KALKBRENNER, F., VIARD, P., SCHULTZ, G. & MIRONNEAU, J. (1997). A betagamma dimer derived from G13 transduces the angiotensin AT1 receptor signal to stimulation of Ca2+ channels in rat portal vein myocytes. Journal of Biological Chemistry 272, 23180-23185 [Abstract/Full Text]
ORIOWO M. A., CHAPMAN, H., KIRKHAM, D. M., SENNITT, M. V., RUFFOLO, R. R. JR & CAWTHORNE, M. A. (1996). The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344. Journal of Pharmacology and Experimental Therapeutics 277, 22-27 [Abstract]
RUIZ-VELASCO V., ZHONG, J., HUME, J. R. & KEEF, K. D. (1998). Modulation of Ca2+ channels by cyclic nucleotide cross activation of opposing protein kinases in rabbit portal vein. Circulation Research 82, 557-565 [Abstract/Full Text]
SCHRODER F. & HERZIG, S. (1999). Effects of beta2-adrenergic stimulation on single-channel gating of rat cardiac L-type Ca2+ channels. American Journal of Physiology 276, H834-843 [Medline]
SHI Q. Y. & COX, R. H. (1995). GTP requirement for isoproterenol activation of calcium channels in vascular myocytes. American Journal of Physiology 269, H195-202 [Medline]
STEA A., SOONG, T. W. & SNUTCH, T. P. (1995). Determinants of PKC-dependent modulation of a family of neuronal calcium channels. Neuron 15, 929-940 [Medline]
STEINBERG S. F. (1999). The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circulation Research 85, 1101-1111 [Full Text]
TANG W. J. & GILMAN, A. G. (1992). Adenylyl cyclases. Cell 70, 869-872 [Medline]
TEWARI K. & SIMARD, J. M. (1994). Protein kinase A increases availability of calcium channels in smooth muscle cells from guinea pig basilar artery. Pflügers Archiv 428, 9-16 [Medline]
TSURU H. & NEGITA, S. (1989). Heterogeneity of beta-adrenoceptor in canine veins: comparison among the facial, portal and saphenous veins. Japanese Journal of Pharmacology 51, 385-395 [Medline]
UEDA N., INIGUEZ-LLUHI, J. A., LEE, E., SMRCKA, A. V., ROBISHAW, J. D. & GILMAN, A. G. (1994). G protein betagamma subunits. Simplified purification and properties of novel isoforms. Journal of Biological Chemistry 269, 4388-4395 [Abstract]
USHIO-FUKAI M., ALEXANDER, R. W., AKERS, M., LYONS, P. R., LASSEGUE, B. & GRIENDLING, K. K. (1999). Angiotensin II receptor coupling to phospholipase D is mediated by the betagamma subunits of heterotrimeric G proteins in vascular smooth muscle cells. Molecular Pharmacology 55, 142-149 [Abstract/Full Text]
VIARD P., EXNER, T., MAIER, U., MIRONNEAU, J., NURNBERG, B. & MACREZ, N. (1999). Gbetagamma dimers stimulate vascular L-type Ca2+ channels via phosphoinositide 3-kinase. FASEB Journal 13, 685-694 [Abstract/Full Text]
VIARD P., MACREZ, N., COUSSIN, F., MOREL, J. L. & MIRONNEAU, J. (2000). beta-3 adrenergic stimulation of L-type Ca2+ channels in rat portal vein myocytes. British Journal of Pharmacology 129, 1497-1505 [Abstract/Full Text]
XIONG Z. & SPERELAKIS, N. (1995). Regulation of L-type calcium channels of vascular smooth muscle cells. Journal of Molecular and Cellular Cardiology 27, 75-91 [Medline]
ZHONG J., DESSAUER, C. W., KEEF, K. D. & HUME, J. R. (1999). Regulation of L-type Ca2+ channels in rabbit portal vein by G protein alphas and betagamma subunits. Journal of Physiology 517, 109-120 [Abstract/Full Text]

Acknowledgements

This study was supported by NIH grants HL-40399 to (K.D.K.) and HL-49254 (to J.R.H.). J.Z. is a recipient of a NRSA postdoctoral fellowship from NIH (HL-10119).

Corresponding author

K. D. Keef: Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA.

Email: kathy{at}physio.unr.edu




This article has been cited by other articles:


Home page
J. Physiol.Home page
G. C. Amberg, M. F. Navedo, M. Nieves-Cintron, J. D. Molkentin, and L. F. Santana
Calcium sparklets regulate local and global calcium in murine arterial smooth muscle
J. Physiol., February 15, 2007; 579(1): 187 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Gao, R. Sadana, C. W. Dessauer, and T. B. Patel
Conditional Stimulation of Type V and VI Adenylyl Cyclases by G Protein beta{gamma} Subunits
J. Biol. Chem., January 5, 2007; 282(1): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Callaghan, J. Zhong, and K. D. Keef
Signaling pathway underlying stimulation of L-type Ca2+ channels in rabbit portal vein myocytes by recombinant Gbeta{gamma} subunits
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2541 - H2546.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Ding, D. Schwartz, P. Posner, and J. Zhong
Hypotonic swelling stimulates L-type Ca2+ channel activity in vascular smooth muscle cells through PKC
Am J Physiol Cell Physiol, August 1, 2004; 287(2): C413 - C421.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Callaghan, S.D. Koh, and K.D. Keef
Muscarinic M2 Receptor Stimulation of Cav1.2b Requires Phosphatidylinositol 3-Kinase, Protein Kinase C, and c-Src
Circ. Res., March 19, 2004; 94(5): 626 - 633.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. M. ROSENFELDT, Y. AMRANI, K. R. WATTERSON, K. S. MURTHY, R. A. PANETTIERI JR, and S. SPIEGEL
Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells
FASEB J, October 1, 2003; 17(13): 1789 - 1799.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhong, J.
Right arrow Articles by Keef, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhong, J.
Right arrow Articles by Keef, K. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS